Patent Assignment
Reel/Frame 018961/0829
Merger and Change of Name
Recorded: 2007-03-06
Pages: 8
Assignor
JONES PHARMA INCORPORATED
Executed: 2004-12-01
Assignee
KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC
501 FIFTH STREET, BRISTOL, TENNESSEE, 37620
Covered Properties
(7)
Process Improvement in the Synthesis of N-[3-(3-Cyano-Pyrazolo[1,5-a] Pyrimidin-7-Yl)Phenyl]-N-Ethylacetamide
Patent:
5,714,607 →
Application:
08/758,132 →
Pharmaceutical Compositions Based on Dalfopristine and on Quinupristine, and Preparation Thereof
Patent:
6,187,746 →
Application:
09/210,938 →
Stabilized Pharmaceutical Compositions, with Quinnupristine and Dalfopristine Base and Their Preparation
Patent:
5,994,338 →
Application:
09/314,070 →
Dalfopristine/Quinupristine Combinations with Cefpirome
Method for Increasing the Bioavailability of Metaxalone
Patent:
6,407,128 →
Application:
09/998,206 →
Levothyroxine Compositions and Methods
Patent:
6,555,581 →
Application:
10/077,677 →
Method for Increasing the Bioavailability of Metaxalone
Related Assignments
(15)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 4, 2001
From: FEGER, CELINE; MOREILLON, PHILIPPE; VOUILLAMOZ, JACQUES
To: AVENTIS PHARMA S.A.
Reel/Frame 012231/0574 →
Assignment of Assignor's Interest
Jul 7, 2003
From: ELAN PHARMACEUTICALS, INC.
To: JONES PHARMA INCORPORATED
Reel/Frame 014237/0019 →
Assignment of Assignor's Interest
Jul 7, 2003
From: ELAN PHARMACEUTICALS, INC.
To: JONES PHARMA INCORPORATED
Reel/Frame 014235/0344 →
Assignment of Assignor's Interest
Aug 18, 2003
From: WYETH HOLDINGS CORPORATION
To: WYETH
Reel/Frame 014373/0676 →
Change of Name
Aug 18, 2003
From: AMERICAN CYANAMID COMPANY
To: WYETH HOLDINGS CORPORATION
Reel/Frame 014373/0673 →
Assignment of Assignor's Interest
Oct 1, 2003
From: AVENTIS PHARMA S.A.
To: JONES PHARMA INCORPORATED
Reel/Frame 014546/0359 →
Assignment of Assignor's Interest
Oct 1, 2003
From: AVENTIS PHARMA S.A.
To: JONES PHARMA INCORPORATED
Reel/Frame 014548/0941 →
Assignment of Assignor's Interest
Oct 1, 2003
From: AVENTIS PHARMA S.A.
To: JONES PHARMA INCORPORATED
Reel/Frame 014546/0355 →
Assignment of Assignor's Interest
Nov 4, 2003
From: WYETH
To: JONES PHARMA INCORPORATED
Reel/Frame 014662/0049 →
Security Agreement
Dec 30, 2008
From: KING PHARMACEUTICALS RESEARCH & DEVELOPMENT, INC.
To: CREDIT SUISSE, AS AGENT
Reel/Frame 022034/0870 →
Release of Security Interest
May 11, 2010
From: KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC.
To: CREDIT SUISSE AG
Reel/Frame 024369/0022 →
Security Agreement
May 13, 2010
From: KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC.
To: CREDIT SUISSE AG
Reel/Frame 025703/0628 →
Release of Security Interest
Feb 3, 2011
From: CREDIT SUISSE AG
To: KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC.
Reel/Frame 025738/0132 →
Change Assignee Address and Correspondence Address
Feb 13, 2017
From: KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC.
To: KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC.
Reel/Frame 041694/0288 →
Assignee and Correspondence Address Change
May 17, 2017
From: KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC.
To: KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC.
Reel/Frame 042486/0322 →